Chris is the Managing Partner of Bridgepoint Europe. Chris also sits on the Firm’s Group Management Committee and is a member of its Investment Advisory Committee. 

He currently sits on the board of Vermaat, and historical transactions include Element, PharmaZell, Vitamin Well, LGC, ERM, Pret A Manger and the delisting of Exova plc.

Chris has a BSc from Exeter University and is ACA qualified. Chris sits on the board of and is involved with charities in the Literacy and wider educational space.

We use strictly necessary cookies to make our site work. Currently the analytics cookies which allow us to collect information about how visitors use our website and help us to improve it; is defaulted to ‘InActive’, if you wish to turn this on you can do so through the Cookie Settings. Please be aware that by blocking some types of cookies it may impact your experience of the site and the services we are able to offer. For more information about any of these cookies and our use of them, or to change your settings at any time, please see Cookie Settings and Cookies Policy.